Second-generation antipsychotic drugs for anxiety disorders

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Depping, Anna M ^a   Komossa, Katja ^a   Kissling, Werner ^a   Leucht, Stefan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL PROTOCOL; DRUG EFFECT; DRUG RESEARCH; DYSTHYMIA; HUMAN; MAJOR DEPRESSION; REVIEW; TREATMENT OUTCOME;

EID: 77950186764     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008120     Document Type: Review

References (33)

1. Allison 1999 Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al.Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry 1999;156(11):1686-96.
2. Altman 1996 Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
3. APA 1980 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM III). Washington DC: American Psychiatric Association, 1980.
4. APA 1987 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition- Revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987.
5. APA 1994 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington DC: American Psychiatric Association, 1994.
6. Arnt 1998 Arnt J, Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics?A review of the evidence. Neuropsychopharmacology 1998;18:63-101.
7. Bland 1997 Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
8. Bystritsky 2006 Bystritsky A. Treatment-resistant anxiety disorders. Molecular Psychiatry 2006;11(9):805-14.
9. Correll 2004 Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of one-year studies. American Journal of Psychiatry 2004;161:414-5.
10. Davidson 1997 Davidson JRT, Miner CM, De Veaugh-Geiss J, Tupler LA, Colket JT, Potts NLS. The Brief Social Phobia Scale: a psychometric evaluation. Psychological Medicine 1997;27:161-66.
11. Der-Simonian 1986 Der-Simonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
12. Divine 1992 Divine GW, Brown JT, Frazer LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7:623-9.
13. Elbourne 2002 Elbourne DR, Altman DG, Higgins JP, Curtin F,Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31:140-9.
14. Furukawa 2006 Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analysis can provide accurate results. Journal of Clinical Epidemiology 2006;59:7-10.
15. Gao 2006 Gao K, Muzina D, Gajawani P, Calabrese JR. Efficacy of Typical and Atypical Antipsychotics for Primary and Comorbid Anxiety Symptoms or Disorders: A Review. Journal of Clinical Psychiatry September 2006;67(9):1372-40.
16. Grant 2006 Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, et al.The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2006;67:363- 74.
17. Gulliford 1999 Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
18. Guy 1976 Guy W. Clinical Global Impressions - ECDEU Asessment Manual Psychopharmacology (DHEW Publ No ADM 76-338). Revised. Rockville MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH, 1976.
19. Hamilton 1959 Hamilton MTI. The assessment of anxiety states by rating. British Journal of Medical Psychology 1959;32:50-5.
20. Hamilton 1960 Hamilton MTI. A rating scale of depression. Journal of Neurology 1960;23:56-62.
21. Hawkridge 2005 Hawkridge S, Ipser JC, Stein DJ. Pharmacotherapy for anxiety disorder in children and adolescents. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD005170.pub2]
22. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
23. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org 2008.
24. Kessler 1994 Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS. Lifetime and 12-month prevalence of DSM-III psychiatric disorders in the United States. Archives of General Psychiatry 1994;51:975-83.
25. Liebowitz 1987 Liebowitz MR. Social Phobia. Modern Problems in Pharmacopsychiatry 1987;22:141-73.
26. Montgomery 1979 Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382-9.
27. Munk-Jorgensen 2006 Munk-Jørgensen P, Allgulander C, Dahl AA, Foldager L, Holm M, Rasmussen I, et al.Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. Psychiatric Services 2006;57:1738-44.
28. Raj 1987 Raj A, Sheehan DV. Medical evaluation of panic attacks. Journal of Clinical Psychiatry 1987;48(8):309-13.
29. Sajatovic 2003 Sajatovic M. Treatment for mood and anxiety disorders: quetiapine and aripiprazole. Current Psychiatry Reports 2003;5(4):320-6.
30. Shear 1997 Shear MK, Brown TA, Barlow DH, et al.Multicenter collaborative Panic Disorder Severity Scale. American Journal of Psychiatry 1997;154:1571-75.
31. Somers 2006 Somers JM, Goldner EM, Waraich P, et al.Prevalence and incidence studies of anxiety disorders: A systematic review of the literature. Canadian Journal of Psychiatry 2006;51:100-3.
32. Vital Signs 2007 Vital Signs. Seroquel led antipsychotics sales in 2006. Clinical Psychiatric News 2007;35:1.
33. WHO 1992 World Health Organisation. International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: World Health Organisation, 1992.